Adam Craig bought $12K of X4 Pharmaceuticals stock
By AlphaYouPublished Form 4
Craig Adam R
Reporting filer
Adam Craig reported buying 4,600 shares of X4 Pharmaceuticals, Inc for about $12K ($2.58 a share on average). Form 4 filed Oct 19, 2026 lists 1 entry.
See the price move since this trade →
- Disclosed
- Oct 19, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Craig Adam R | 2026-10-16 | P | Purchase | 4600 | 2.5834 | 333,251 | 3 days | Filed terms
|
Common Stock
- Owner
- Craig Adam R
- Date
- 2026-10-16
- Code
- P
- Action
- Purchase
- Quantity
- 4600
- Price
- 2.5834
- Following holdings
- 333,251
- Reporting delay
- 3 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-16
- transaction Form Type: 4
- transaction Code: P
- equity Swap Involved: 0
- transaction Shares: 4600
- transaction Price Per Share: 2.5834
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 333251
- id: F1
- id: F2
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Craig Adam R: Executive Chairman, Director.
- F1: Of the shares of common stock reported, 193,254 shares represent restricted stock units.
- F2: The Reporting Person has agreed to disgorge to the Issuer all profits deemed to be realized from this transaction pursuant to Section 16(b) of the Securities Exchange Act of 1934, as amended.
Original sources
Prepared automatically from public filing data. Report a correction.